secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001193125-25-140810
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Whitehawk Therapeutics shareholders elect three Class II directors at annual meeting
--------------------------------------------------------------------------------

- Three Class II directors elected: Anupam Dalal (18.5M for, 5.0M withheld), Mohammad Hirmand (19.4M for, 4.2M withheld), David Lennon (19.4M for, 4.2M withheld).
- Board size decreased from 10 to 9 directorships upon opening of polls.
- Advisory vote on executive compensation passed: 18.9M for, 4.7M against, 14k abstentions.
- Ratification of BDO USA as auditor for FY2025 approved with 28.1M for, 524k against, 101k abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312525140810/0001193125-25-140810-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312525140810/d928055d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-140810

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer